Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Pfizer Wins FDA Panel's Backing for Kidney-Cancer Treatment
Dec. 9, 2011
Pfizer Inc., the world's biggest drugmaker, won a U.S. panel's backing for an experimental medicine for advanced kidney cancer in patients who have failed prior treatments.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing